Cargando…
Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells
BACKGROUND: Autologous cellular immunotherapy or immune enhancement therapy has demonstrated some promising benefits for prostate cancer. T cell-based immunotherapy or sipuleucel-T therapy has yielded certain beneficial responses and a slight improvement on the overall survival of patients with meta...
Autores principales: | Wang, Zhu, Li, Youjia, Wang, Yuliang, Wu, Dinglan, Lau, Alaster Hang Yung, Zhao, Pan, Zou, Chang, Dai, Yong, Chan, Franky Leung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079411/ https://www.ncbi.nlm.nih.gov/pubmed/32183880 http://dx.doi.org/10.1186/s13287-020-01634-6 |
Ejemplares similares
-
Correction: Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence
por: Wang, Zhu, et al.
Publicado: (2020) -
Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence
por: Wang, Zhu, et al.
Publicado: (2019) -
Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis
por: Yuan, Xin, et al.
Publicado: (2021) -
Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
por: Du, Hansong, et al.
Publicado: (2020) -
Development of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cells
por: Gao, Weijie, et al.
Publicado: (2018)